¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷) : 2021-10-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷) : 2021-10-02
±³À°ÀÏÀÚ : 2021-10-02
±³À°Àå¼Ò : ½Ç½Ã°£ È­»ó°­ÀÇ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp3@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø 10¸¸¿ø/ÁØȸ¿ø Àü°øÀÇ,º´¸®»ç 8¸¸¿ø/ºñȸ¿ø 25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-02 CHANNEL1 09:00~09:30 What is the preferred marker of Cardiac Myocyte injury or death in 2021?  William E. Winter(University of Florida Gainsville USA) 
±³À°½Ã°£ 10-02 CHANNEL1 09:30~10:00 ½ÉºÎÀü Ç¥ÁöÀÚ  Yonggeun Cho(Hallym University Sacred Heart Hospital Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 10:00~10:30 ½ÉÇ÷°üÀ§Çèµµ Ç¥ÁöÀÚ  Soo Young Moon(Pusan National University School of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 09:00~09:20 The role of public agency in strengthening the national capacity for diagnosis of infectious diseases  Jae-Sun Park(Korea Disease Control and Prevention Agency Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 09:20~09:40 The role of academic society in strengthening the national capacity for diagnosis of infectious diseases  Hyukmin Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 09:40~10:00 National surveillance system for COVID-19 variant  Jee Eun Lee(Korea Disease Control and Prevention Agency Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 10:00~10:30 National diagnostic system after vaccination  Jae-Seok Kim(Hallym University College of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 11:00~12:00 Point of care molecular testing  David R. Peaper(Yale University School of Medicine USA) 
±³À°½Ã°£ 10-02 CHANNEL1 12:00~12:30 Laboratory medicine & healthcare excellence  Tricia Ravalico(Abbott) 
±³À°½Ã°£ 10-02 CHANNEL1 12:00~12:30 Laboratory medicine & healthcare excellence  Colleen Strain(Abbott) 
±³À°½Ã°£ 10-02 CHANNEL1 12:40~13:20 How to implement a PBM program at your hospital  Mark Yazer(University of Pittsburgh USA) 
±³À°½Ã°£ 10-02 CHANNEL1 13:30~14:00 AdvanSure SARS-CoV-2 IgG ELISA for monitoring immune response after infection or vaccination  Eun-Jee Oh(The Catholic University of Korea College of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 14:00~14:20 CAR-T cell therapy and apheresis support  Kyoung Un Park(Seoul National University College of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 14:20~14:40 CAR-NK cell therapy and ex vivo expansion of NK cells  Duck Cho(Sungkyunkwan University School of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 14:40~15:00 GMP for cell therapy and advanced regenerative bio act  Jong Wook Chang(Samsung Medical Center & ENCell Co. Ltd Korea) 
±³À°½Ã°£ 10-02 CHANNEL1 15:00~15:30 Lentiviral vector for cell and gene therapy  Brian (Byoung) Ryu(Umoja Biopharma USA) 
±³À°½Ã°£ 10-02 CHANNEL2 14:00~14:20 Regulation plan of manufacturing and distribution of IVD  Hongmo Seong(Ministry of Food and Drug Safety Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 14:20~14:40 Regulation of post-market surveillance of foreign countries  Young-Wook Ahn(Ministry of Food and Drug Safety Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 14:40~15:00 Plan of collection and evaluation of IVD  Kyoung Ho Roh(National Health Insurance Service Ilsan Hospital Korea) 
±³À°½Ã°£ 10-02 CHANNEL2 15:00~15:30 Optimal distribution and storage plan in domestic IVD company  Young Kyung Lee(Hallym University Kangdong Sacred Heart Hospital Korea) 
±³À°½Ã°£ 10-02 CHANNEL3 14:00~14:20 Quality control in routine hematology  Ji-Myung Kim(Chungnam National University College of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL3 14:20~14:40 Quality control in clinical microbiology  In Young Yoo(Seoul St. Mary) 
±³À°½Ã°£ 10-02 CHANNEL3 14:40~15:00 Quality control in flow cytometry  Kyung-Hwa Shin(Pusan National University School of Medicine Korea) 
±³À°½Ã°£ 10-02 CHANNEL3 15:00~15:30 Quality control of histocompatibility test  Borae G. Park(Korea University Guro Hospital Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷) : 2021-10-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹Ãµ½Ä¾Ë·¹¸£±âÇùȸ 2021 Post Graduate Asthma School (1ÀÏÂ÷) : 2021-10-02
´ÙÀ½±Û ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2021-10-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20953 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ - Á¦4Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-20 0 3 2024-06-14
20952 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ´ëÇѺ´¸®ÇÐȸ ÁöµµÀü¹®ÀÇ ¿öÅ©¼¥ : 2024-06-19 0 2 2024-06-14
20951 ±¤ÁÖ ´ëÇÑÇǺΰúÇÐȸ Á¦172Â÷ È£³²Áöȸ : 2024-06-19 0 2 2024-06-14
20950 ¿ï»ê ´ëÇѳ»°úÇÐȸ ¿ï»êÁöȸ ¿¬¼ö°­Á : 2024-06-19 0 3 2024-06-14
20949 ´ë±¸ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ´ë±¸°æºÏÁöȸ 2024³â 2Â÷ Áý´ãȸ : 2024-06-19 0 3 2024-06-14
20948 Á¦ÁÖ 2024³â Á¦2Â÷ Á¦ÁÖ´ëÇб³º´¿ø ¾È°ú Áý´ãȸ : 2024-06-18 0 3 2024-06-14
20947 ´ë±¸ 2024 ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö°­Á : 2024-06-18 0 4 2024-06-14
20946 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 6¿ù Çмú½ÉÆ÷Áö¾ö : 2024-06-17 0 2 2024-06-14
20945 ¼­¿ï 2024 Á¦3Â÷ ´ëÇѾȰúÀÇ»çȸ ½ÉÆ÷Áö¿ò : 2024-06-17 0 1 2024-06-14
20944 ´ëÀü ´ëÇÑ»êºÎÀΰúÀÇ»çȸ Àڱ󻸷¾ÏÀÇ °¡ÀÓ·Â º¸Á¸ : 2024-06-17 0 0 2024-06-14
20943 °­¿ø ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á ¹× º¸Çè½É»çÀ̽´¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß : 2024-06-17 0 0 2024-06-14
20942 ¼­¿ï 2024³â ´ëÇÑ¿©¼º¼ºÀÇÇÐȸ Á¦17ȸ Ãá°èÇмú´ëȸ : 2024-06-16 0 3 2024-06-14
20941 ¼­¿ï Á¦28ȸ ¼­¿ï½Ã³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Çмú´ëȸ : 2024-06-16 0 2 2024-06-14
20940 ´ë±¸ Á¦22Â÷ ´ë°æÇǺÎÄ¡·áÇмú´ëȸ : 2024-06-16 0 3 2024-06-14
20939 ¼­¿ï ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ (¿Â¶óÀÎ) Á¦ 5ȸ ¼Ò¾Æ ÁøÁ¤ ±âº» ¿öÅ©¼ó : 2024-06-16 0 1 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷